Portfolio comparison
Genentech Inc vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Genentech Inc
Patents indexed
13
Year range
1982 – 2017
Most recent
2017
biotechpharmaceuticalgene_editinghealthcareoncology
Top Patents13 enriched
US 4816567· 1989
Making Hybrid Antibodies from Different Animals
US 7527791· 2009
How Engineered Antibodies Target TGF-beta Proteins to Fight Cancer
US 6054297· 2000
How to Redesign Mouse Antibodies for Safe Use in Humans
Activity by Decade
1980s2
2000s8
2010s3
Company B
Immatics Biotechnologies
Patents indexed
3
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapygene_editingoncology
Top Patents3 enriched
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
US 12168044· 2024
Treating Liver Cancer with Specially Trained Immune Cells
US 11542303· 2023
How a Specific Peptide Boosts the Immune System Against Cancer
Activity by Decade
2010s1
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.